Introduction: Secretory immunoglobulin A (SIgA) is an antibody that plays an important role in mucosal immunity by blockading epithelial receptors inhibiting the attachment of pathogenic bacteria, especially Streptococcus mutans to epithelial cells. Lactobacillus is one of the bacteria contained in probiotics, which can increase the proliferation of SIgA-producing cells. This study aims to determine the effect of probiotic Lactobacillus casei supplementation on increasing SIgA levels in saliva of wistar rats. Methods: This study used a laboratory prospective experimental research design, with a simple randomized design in which thirtysix male wistar rats were adapted for 7 days. After adaptation, the experimental animals that fulfilled the inclusion criteria were divided into 2 groups randomly, i.e., the treatment group who received probiotic supplement Lactobacillus casei 1.17ml / 200gBW twice daily, and the control group receiving only standard water and food, the intervention was performed for 14 days. Examination of SIgA levels in saliva was conducted with ELISA. Results: Based on Mann-Whitney analysis, the results showed significant differences in SIgA levels between treatment and control groups with median SIgA values of 26.668 ng /ml and 4,463 ng/ml, with p values being 0.033 (p <0.05). Conclusion: Probiotic supplementation of Lactobacillus casei could increase SIgA levels in saliva of wistar rats. 
INTRODUCTION
The ability of a bacterium to form complex multidimensional structures or biofilms plays an important role in some diseases. The most common disease found in the oral cavity is dental caries. Streptococcus mutans are one of many etiological factors of dental caries disease. These bacteria can acquire new properties for the determinants of pathogenic expression that determine their virulence under certain conditions. Through the adhesion mechanism to the solid surface, Streptococcus mutans can colonize within the oral cavity and form a bacterial biofilm. Also, these bacteria are also able to survive in acidic environmental conditions and interact with other specific microorganisms in the oral cavity.
1
The cariogenic properties of Streptococcus mutans are derived from the enzyme glucosyltransferase. This enzyme has virulence factor in pathogenesis caries, because it can convert sucrose to glucan. Glucan is a component of the dental plaque matrix structure and serves as an early bacterial attachment medium on the tooth surface, facilitating bacterial accumulation and as a source of extracellular polysaccharide reserves.
1,2
Another protein produced by Streptococcus mutans is the glucan binding protein. This protein serves to bind the glucan in bacteria, thus contributing to the adhesion of microorganisms and the formation of biofilms. Also, Streptococcus mutans are also known to have surface proteins called antigen I/II (Ag I/II), that have adhesive properties and play a role in the attachment of Streptococcus mutans with acquired pellicles on tooth surfaces.
3
A mucosal barrier is a form of innate immune system in the oral cavity. Antibodies or immunoglobulins are adaptive immune systems that provide the body's defense against various pathogenic microorganisms. Secretion immunoglobulin A (SIgA) is a major class of antibodies contained in secretions of body fluids such as saliva, tears and mucus from the digestive tract. Secretion immunoglobulin A is the dominant adaptive immune defense in the oral cavity. These immunoglobulins can inhibit the attachment of Streptococcus to oral mucosal epithelial cells, agglutinate bacteria, neutralize pathogens in the oral cavity and serve as a mucosal barrier and macrophage activation.
4-6
The use of antibiotics in treating inflammation caused by infection of the teeth, causes many adverse effects to the human body. The adverse effects of current use of antibiotics include the emergence of allergic reactions, toxicity, bacterial 
7,8
It has been proven in recent years that the loss of effectiveness of antibiotics is associated with the evolution of pathogenic bacteria that become resistant. This is the cause of treatment failure. Therefore it is necessary to continue to look for alternative drug replacement antibiotics, namely probiotics that can provide health benefits for the body with minimal side effects. In addition, the probiotic production process is more economical than chemicals in other drugs so that it can be developed in various forms of therapy.
9
Probiotics have long been known for their benefits in the field of health, but the use of probiotics in the field of dentistry is still very little. Therefore, today there is a tendency to try clinical trials of probiotics to reduce the side effects of antibiotics. Probiotics are supplements that contain living microorganisms that can actively improve health by improving the balance of oral microflora. The benefits of probiotics for the health of the body can be through three mechanisms of function which are protective function, immune system function and probiotic metabolite function. Protective function is the ability to inhibit pathogenic bacteria in the oral cavity, with the presence of colonization of probiotic bacteria in the oral cavity, there will be competition of nutrition and competition where attachment between probiotic bacteria and pathogen bacteria.
Probiotic bacteria can also produce antibacterial components (bacteriocins) that can suppress the growth of pathogenic bacteria, so it can be used to control the number of Streptococcus mutans in plaque and oral cavity, as the main bacteria that cause caries. The benefits of probiotics in improving the body's immune system is through the ability of probiotics to induce SIgA formation, macrophage activation, modulation of pro-inflammatory cytokines, producing vitamins and lactic acid that function as antioxidants.
9,10
Probiotic bacteria are found in many foods and dairy products, whether contained or added to the product. Microorganisms that are often used in probiotics are lactic acid bacteria such as Lactobacillus and Bifidobacteria. Lactic acid bacteria are a group of bacteria that produce bacteriocin, an antimicrobial peptide compound which has bactericidal or bacteriostatic properties against other species.
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Several studies in the field of dentistry previously stated that probiotic bacteria Lactobacillus rhamnosus and Lactobacillus reuteri in interaction with Streptococcus mutans could reduce the number of pathogenic bacteria. Other studies have suggested that Lactobacillus acidophilus present in yogurt can colonize and adhere to the enamel surface of the tooth. This shows the role of probiotics in dental caries prophylaxis. Administering Lactobacillus paracasei for two weeks through oral shows a very effective probiotic action. The treatment of Lactobacillus fermentum and Lactobacillus plantarum for two weeks in rats was able to increase SIgA level in the small intestine mucosa. Another strain of Lactobacillus found in the probiotic supplement is Lactobacillus casei. These bacteria are beneficial bacteria that are naturally found in the oral cavity and human intestines. Lactobacillus casei is a Gram-positive, anaerobic, rod-shaped bacterium, living at 15° C and belonging to the hetero-fermentative group. 16 The use of Lactobacillus casei in this prevention of caries is one of the attempts to control dental plaque, which can be done by inhibiting the growth of pathogenic bacteria Streptococcus mutans by utilizing the mechanism of action of probiotic bacteria. By increasing SIgA in saliva, in addition to SIgA function as barrier by strengthening the oral mucosal epithelium, SIgA will bind to the epitope of the antigen I/II part of Streptococcus mutans, so that the andesine cannot bind to the salivary particle, then Streptococcus mutans cannot colonize on the tooth surface. Inhibition of plaque matrix formation and inhibition of bacterial aggregation initiation may prevent early colonization of bacteria. Attempts to inhibit initial colonization are expected to prevent the formation of late colonization, thus preventing the formation of dental plaque.
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The purpose of this study was to determine effect of probiotics Lactobacillus casei supplement on SIgA saliva level of wistar rats
MATERIAL AND METHODS
The research objects used 36 male wistar rats aged 8-12 weeks, obtained from animal research laboratory, University of Padjadjaran Bandung. Inclusion criteria were male sex rats, age 8-12 weeks, weight 200-250 grams and healthy. The exclusion criteria were rats with salivary gland disease, weighing more than 10% during adaptation of the research process and rats receiving high-carbohydrate supplements (80%) higher than standard feeding. The type of this study was pure experimental (prospective intervention). The sampling technique used was simple random sampling technique. The independent variable is the provision of probiotic supplement while the dependent variable is SIgA level.
The material used in this study was Lactobacillus casei probiotic supplement with a dose of 1.17ml/200g BW, Spuit 3cc, 1cc syringe, gloves, mask, mouse cage, saliva box, oral sonde. The instrument used for the inspection of SIgA were ELISA kit IgA, blue and yellow tip, 450 ± nm filter reader, multichannel pipette and disposable tip, Eppendorf tube for diluting sample, distilled water, container wash solution, precision pipette (2 μL to 200 μL) and timer. To increase the amount of saliva, rats in pilocarpine were injection with a dose of 0.144mg /200gBW. The rat's hyperactivity during salivary uptake was overcome by injection of 1.35 mg/200g mouse ketamine.
The number of repetitions in this study used the formula of Federer: (n-1) (t-1) ≥15, obtained n≥16, added with 10% dropout criteria, to anticipate dead and sick rats during the study, therefore there were 18 rats in each group. In this study there are two groups, then the total number of rats used in this study was 36.
Here is how it works, at first before the research, rats were adapted in the laboratory for 7 days given standard food and drink (HI-GRO medicated 551.2) Rats fulfilling inclusion criteria were divided into two groups: control group given only standard feeding and drinking and treatment group given probiotic supplement Lactobacillus casei per oral 1.17ml / 200gBW, given 2 times daily at 09.00 and 15.00 for 14 days. 3) On the 14th-day 
RESULT
Before the SIg A examination is conducted on the sample, the standard determination is done first. The standard measurement results are represented by a linear curve as shown in Table 1 and Figure 1 . From the standard curve showing the linear form, we found an equation of y = 386.1 (×) -37.63 which will be used to determine the calculated content SIgA in the sample that has been known the absorbance value (as coofsien ×), as seen in Table 2 . Box Plot SIgA level of experimental animal as seen in Figure 2 .
The data normality test using Saphiro-Wilk test showed abnormal data distribution (p < 0.05), as seen in Table 3 , Mann-Whitney analysis was performed in both groups which showed significant difference with p = 0.033(p < 0.05), it can be concluded that administering probiotic Lactobacillus casei 1.17 ml/200gBW 2 times daily for 14 days can increase SIgA levels in saliva of wistar rats.
DISCUSSION
Dental caries is an infectious disease of hard tooth tissue; the disease is caused by pathogenic bacteria in the oral cavity. Streptococcus mutans are said to be the main cause of caries that begins with the formation of plaque on the tooth surface. Various studies have been done to suppress the number of Streptococcus mutans in the oral cavity, such as studies using probiotics to increase SIgA in saliva and oral mucosa.
4,18
Administration of probiotics containing Lactobacillus casei in this study is expected to modulate the immune system by increasing levels of SIgA saliva of wistar rats. In this study, there were significant differences in SIgA levels in both groups of experimental animals, where the SIgA group treatment was higher than the control group. This suggests that administering Lactobacillus casei probiotics twice daily for 14 days may increase SIgA levels in the saliva of wistar rats.
Probiotic bacteria can affect both local and humoral immune systems. In cellular immune response it is said that probiotics will increase splenocytes proliferation as a result of mitogen in T-cells and B-cells. Lactobacillus rhamnosus can increase the number of SIgA-producing cells and other immunoglobulin-producing cells, and stimulate the release of local interferons that facilitate antigen processing.
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Increased levels of SIgA saliva in this study, allegedly because the probiotic benefits of Lactobacillus casei in improving the body's immune system is through the ability of probiotics induce SIgA formation. This is in line with the study of Wresdiyati et al. (2013) whereas probiotics are present in enhancing the body's immune system through probiotic capability inducing SIgA formation, macrophage activation, pro-inflammatory cytokines, producing vitamins and lactic acid that act as antioxidants. 10 Other studies also suggest that SIgA is a major class antibody present in secretion of body fluids such as saliva, tears or gastrointestinal mucous. SIgA is dominant in the immune system of the mucous membrane which is the first defense against the dangers of environmental factors. As we know, SIgA saliva is a predominant protein in humoral mucosal response, and plays a role in neutralizing toxins, viruses and exotoxins and eliminating pathogenic microorganisms.
16,18
Probiotics also contribute to increased cytokine production, for example the Streptococcus thermophilus strain will increase the production of cytokines TNF and IL-6 via macrophage cells. Lactobacillus bulgaricus strain, Bifidobacterium culolescenti, and Bifidobacterium bifidum will increase the production of IL-6 through T-helper cells. The role of probiotics in non-specific immunity is the ability to increase the effects of phagocytosis against pathogens and can reduce hypersensitive reactions.
19
Probiotic bacterial protective function of Lactobacillus casei is suspected to inhibit pathogenic bacteria in the oral cavity, in the presence of colonization of probiotic bacteria in the oral cavity, there will be nutritional competition and competition where attachment between probiotic bacteria and pathogen bacteria. 9 SIgA secretion can cause agglutination of pathogenic bacteria and inhibit attachment of bacteria to the epithelial cells of the mucous membrane. In addition, another study suggests that the role of SIgA in inhibiting the attachment of pathogenic bacteria Streptococcus mutans as a cause of dental plaque is that SIgA binds to the epitope of the surface protein possessed by Streptococcus mutans i.e. antigen I / II, so that the epitope cannot bind to the salivary particle this will cause Streptococcus mutans to not colonize the tooth surface.
1,3,18
Lactobacillus casei can thrive at a very acidic pH that is at a pH below 3, even at pH 2 can survive despite significant colonic degradation. 16 Thus this bacterium can compete with pathogenic bacteria Streptococcus mutans in acidic atmosphere in the oral cavity. In line with Meurman et al. who also demonstrated the activity of Lactobacillus rhamnosus GG against Streptococcus mutans at low pH and the bacteria easily prevent the cariogenic effect of the Streptococcus mutans.
13

CONCLUSION
There is an increase of SIgA level in saliva of wistar rats receiving probiotic supplementation of Lactobacillus casei in preventing dental caries. Administration of probiotic supplementation Lactobacillus casei can be recommended as adjuvant in preventive therapy of dental plaque formation, so it can reduce the number of dental caries in the community, after a dose test and clinical trials.
